These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19863326)

  • 21. Differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia using phonatory break analysis.
    Roy N; Whitchurch M; Merrill RM; Houtz D; Smith ME
    Laryngoscope; 2008 Dec; 118(12):2245-53. PubMed ID: 19029863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of muscle tension dysphonia and adductor spasmodic dysphonia using spectral moments of the long-term average spectrum.
    Houtz DR; Roy N; Merrill RM; Smith ME
    Laryngoscope; 2010 Apr; 120(4):749-57. PubMed ID: 20222024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin therapy for abductor spasmodic dysphonia.
    Woodson G; Hochstetler H; Murry T
    J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term results of laryngeal framework surgery--thyroplasty type 1: A pilot study.
    Harries ML; Morrison M
    J Otolaryngol; 1995 Oct; 24(5):281-7. PubMed ID: 8537986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioplastique injection laryngoplasty: voice performance outcome.
    Hamilton DW; Sachidananda R; Carding PN; Wilson JA
    J Laryngol Otol; 2007 May; 121(5):472-5. PubMed ID: 17164022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia.
    Roy N; Gouse M; Mauszycki SC; Merrill RM; Smith ME
    Laryngoscope; 2005 Feb; 115(2):311-6. PubMed ID: 15689757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midline lateralization thyroplasty for adductor spasmodic dysphonia.
    Isshiki N; Tsuji DH; Yamamoto Y; Iizuka Y
    Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):187-93. PubMed ID: 10685572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of adductor-type spasmodic dysphonia from muscle tension dysphonia by spectral analysis.
    Rees CJ; Blalock PD; Kemp SE; Halum SL; Koufman JA
    Otolaryngol Head Neck Surg; 2007 Oct; 137(4):576-81. PubMed ID: 17903573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thyroplasty by external approach with silastic prosthesis in the treatment of laryngeal paralysis].
    Chevalier D; Fayoux P; Decorte D; Delporte N; Piquet JJ
    Ann Otolaryngol Chir Cervicofac; 1997; 114(5):191-5. PubMed ID: 9686030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of thyroplasty in the management of sulcus vocalis.
    Kandoğan T
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):13-7. PubMed ID: 17483605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective lateral laser thyroarytenoid myotomy for adductor spasmodic dysphonia.
    Hussain A; Shakeel M
    J Laryngol Otol; 2010 Aug; 124(8):886-91. PubMed ID: 20426891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative complications and safety of type II thyroplasty (TPII) for adductor spasmodic dysphonia.
    Mizoguchi K; Hatakeyama H; Yanagida S; Nishizawa N; Oridate N; Fukuda S; Homma A
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2215-2223. PubMed ID: 28229294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment for adductor spasmodic dysphonia--efficacy of bilateral thyroarytenoid myectomy under microlaryngoscopy.
    Nakamura K; Muta H; Watanabe Y; Mochizuki R; Yoshida T; Suzuki M
    Acta Otolaryngol; 2008; 128(12):1348-53. PubMed ID: 18607929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arytenoid adduction combined with Gore-Tex medialization thyroplasty.
    McCulloch TM; Hoffman HT; Andrews BT; Karnell MP
    Laryngoscope; 2000 Aug; 110(8):1306-11. PubMed ID: 10942131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Comparison of Thyroarytenoid Muscle Myectomy and Type II Thyroplasty for Spasmodic Dysphonia.
    Nomoto M; Tokashiki R; Hiramatsu H; Konomi U; Motohashi R; Sakurai E; Toyomura F; Ueda Y; Inoue S; Tsukahara K; Suzuki M
    J Voice; 2015 Jul; 29(4):501-6. PubMed ID: 25737474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic assessment of Isshiki type III thyroplasty.
    Slavit DH; Maragos NE; Lipton RJ
    Laryngoscope; 1990 Aug; 100(8):844-8. PubMed ID: 2166191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional significance of arytenoid adduction with the suture attaching to cricoid cartilage versus to thyroid cartilage for unilateral paralytic dysphonia.
    Su CY; Tsai SS; Chuang HC; Chiu JF
    Laryngoscope; 2005 Oct; 115(10):1752-9. PubMed ID: 16222189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional results after external vocal fold medialization thyroplasty with the titanium vocal fold medialization implant.
    Schneider B; Denk DM; Bigenzahn W
    Laryngoscope; 2003 Apr; 113(4):628-34. PubMed ID: 12671418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CO2 laser cordectomy: analysis of morpho-functional results].
    Iengo M; Villari P; Masula I; De Clemente M
    Acta Otorhinolaryngol Ital; 2000 Apr; 20(2):106-20. PubMed ID: 10992603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Titanium bridge modification for type 2 thyroplasty to improve device mechanical & safety performance.
    Sanuki T; Nishimura T; Aburada T; Fukushima M
    Auris Nasus Larynx; 2022 Jun; 49(3):460-467. PubMed ID: 34742621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.